Cardio Diagnostics Holdings, Inc. (CDIO) Revenue History
Annual and quarterly revenue from 2020 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
CDIO Revenue Growth
CDIO Revenue Analysis (2020–2024)
As of May 8, 2026, Cardio Diagnostics Holdings, Inc. (CDIO) generated trailing twelve-month (TTM) revenue of $15,782, reflecting significant decline in growth of -56.6% year-over-year. The most recent quarter (Q3 2025) recorded $2,855 in revenue, down 61.8% sequentially.
Looking at the longer-term picture, CDIO's historical revenue data shows a 3-year CAGR of +238.3%. The company achieved its highest annual revenue of $34,890 in 2024, representing a new all-time high.
When compared to Healthcare sector peers including HLIO (+4.1% YoY), EXAS (+17.7% YoY), and NTRA (+35.9% YoY), CDIO has underperformed the peer group in terms of revenue growth. Compare CDIO vs HLIO →
CDIO Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CDIOCurrent | $15,782 | -56.6% | - | -23977.9% | |
 HLIO | $839M | +4.1% | +9.9% | 7.9% | |
 EXAS | $3.2B | +17.7% | +16.8% | -6.4% | |
 NTRA | $2.3B | +35.9% | +42.6% | -13.4% | |
 TMDX | $605M | +30.2% | +88.2% | 17.9% | |
 HOLX | $4.1B | +2.2% | +1.7% | 17.4% |
CDIO Historical Revenue Data (2020–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $35K | +104.5% | $35K | 100.0% | $-8,365,877 | -23977.9% |
| 2023 | $17K | +1696.3% | $17K | 100.0% | $-7,242,459 | -42440.4% |
| 2022 | $950 | +5.4% | $950 | 100.0% | $-4,548,451 | -478784.3% |
| 2021 | $901 | - | $901 | 100.0% | $-620,448 | -68862.2% |
| 2020 | $0 | - | $0 | - | $-609,164 | - |
See CDIO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CDIO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CDIO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCDIO — Frequently Asked Questions
Quick answers to the most common questions about buying CDIO stock.
Is CDIO's revenue growth accelerating or slowing?
CDIO revenue declined -56.6% year-over-year, contrasting with the 5-year CAGR of N/A. TTM revenue fell to $15782.00. This reverses the prior growth trend.
What is CDIO's long-term revenue growth rate?
Cardio Diagnostics Holdings, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of -56.6% is below this long-term average.
How is CDIO's revenue distributed by segment?
CDIO reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2020-2024 are available for download. Segment mix reveals concentration and diversification trends.